Novartis Investigative Site

Inverness, Invernesshire IV2 3RE

1 studies enrolling now · 4 studies all time

What they study most

Chronic Heart Failure With Reduced Ejection Fraction, Generalized Myasthenia Gravis, Psoriatic Arthritis, Relapsing Multiple Sclerosis

Studies at this site

• A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. — Recruiting now
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis — Completed
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed